Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Synergy Between NK Cells and Monocytes in Potentiating Cardiovascular Disease Risk in Severe COVID-19.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: July 11, 2024
NK cell dysregulation may potentiate cardiovascular disease in adolescents with perinatally acquired HIV on antiretroviral therapy.
Journal: Nature communications
Published: June 11, 2024
Activated NK Cells with Pro-inflammatory Features are Associated with Atherogenesis in Perinatally HIV-Acquired Adolescents.
Journal: medRxiv : the preprint server for health sciences
Published: November 21, 2023
Synergistic Role of NK Cells and Monocytes in Promoting Atherogenesis in Severe COVID-19 Patients.
Journal: medRxiv : the preprint server for health sciences
Published: November 21, 2023
A Randomized Clinical Trial of Transgender Women Switching to B/F/TAF: The (mo)BETTA Trial.
Journal: Open forum infectious diseases
Published: February 28, 2023
Heroin Use Is Associated With Vascular Inflammation in Human Immunodeficiency Virus.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 10, 2022
Estrogen May Enhance Toll-Like Receptor 4-Induced Inflammatory Pathways in People With HIV: Implications for Transgender Women on Hormone Therapy.
Journal: Frontiers in immunology
Published: February 19, 2022
Impact of Heroin and HIV on Gut Integrity and Immune Activation.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: August 12, 2021
Levels of Soluble CD14 and Tumor Necrosis Factor Receptors 1 and 2 May Be Predictive of Death in Severe Coronavirus Disease 2019.
Journal: The Journal of infectious diseases
Published: September 15, 2020
In Vitro Exposure of Leukocytes to HIV Preexposure Prophylaxis Decreases Mitochondrial Function and Alters Gene Expression Profiles.
Journal: Antimicrobial agents and chemotherapy
Published: August 13, 2020
Immunomodulatory and Anti-Inflammatory Strategies to Reduce Comorbidity Risk in People with HIV.
Journal: Current HIV/AIDS reports
Published: June 15, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026